Policy | March 16, 2023
2654 compounds screened for different activities for GPCR profiling: Dr Jitendra Singh
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
Biocorp will receive an initial milestone payment this year
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
Cleocin Hydrochloride Capsules market achieved annual sales of approximately US $33.6 million
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
A funding to expand operations and provide better patient care
Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.
Proposed combination enhances Pfizer’s position as a leading company in oncology
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
The company will be submitting the responses to US FDA observations within stipulated timeline
Subscribe To Our Newsletter & Stay Updated
